(Q35557428)

8 August 2017

1 reference

title

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity (English)

1 reference

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1359-6446(03)02864-2

20 March 2024

author name string

Dante J. Marciani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14554157

20 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14554157

20 March 2024

publication date

1 October 2003

1 reference

8 August 2017

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14554157

full work available at URL

20 March 2024

https://api.elsevier.com/content/article/PII:S1359644603028642?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1359-6446(03)02864-2

https://api.elsevier.com/content/article/PII:S1359644603028642?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1359-6446(03)02864-2

20 March 2024

1 reference

8 August 2017

volume

8

1 reference

8 August 2017

issue

20

1 reference

8 August 2017

page(s)

934-943

1 reference

An overview of the immune system

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Therapeutic vaccines: realities of today and hopes for the future

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Toll-like receptors in the induction of the innate immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

The role of B7 costimulation in T-cell immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Activation and inhibition of lymphocytes by costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

1 reference

7 January 2021

Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

The mannose receptor is a pattern recognition receptor involved in host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

1 reference

7 January 2021

Toll-like receptors as sensors of pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Overview of vaccine adjuvants: present and future

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Covalent chemical events in immune induction: fundamental and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

The lineage decisions of helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Mammalian Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Lipopolysaccharide: Structure, Bioactivity, Receptors, and Signal Transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Monophosphoryl lipid A activates both human dendritic cells and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Liposomes as carriers of antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Therapeutic intervention with complement and beta-glucan in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Activation of macrophages by linear (1right-arrow3)-beta-D-glucans. Impliations for the recognition of fungi by innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Design, synthesis, and immunostimulatory properties of CpG DNAs containing alkyl-linker substitutions: role of nucleosides in the flanking sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

CpG DNA in the prevention and treatment of infections

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Discovery of immunopotentiatory drugs: current and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

The role of CTLA-4 in the regulation of T cell immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

The Paradox of Immune Molecular Recognition of α-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for αβ TCRs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

NKT cells: potential targets for autoimmune disease therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Towards immunotherapy for chronic hepatitis B virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Prospects for the therapeutic use of anticancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902864-2

7 January 2021

Lymphocyte migration: an essential step in understanding the effects of vaccination

series ordinal

13

1 reference

https://api.crossref.org/works/10.1016/S1359-6446(03)02864-2

20 March 2024

Identifiers

1 reference

8 August 2017

1 reference